Anti-MRSA agent 13

Description

Anti-MRSA agent 13 Compound 9b is an agent against methicillin-resistant Staphylococcus aureus MRSA , exhibiting a minimum inhibitory concentration MIC of 0.5AAasAasAa2 ?g/mL against clinically isolated MRSA strains. Anti-MRSA agent 13 possesses favorable biosafety, plasma tolerance stability, and a low tendency to develop resistance. Anti-MRSA agent 13 disrupts cell walls and membranes, reduces metabolic activity, causes oxidative damage, affects DNA function, and ultimately leads to MRSA death through multi-target synergies.